{"id":"https://openalex.org/W1503699774","doi":null,"title":"Finance of Small Bio-pharmaceutical Industry in Finland - Descriptive Analysis","display_name":"Finance of Small Bio-pharmaceutical Industry in Finland - Descriptive Analysis","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W1503699774","mag":"1503699774"},"language":"en","primary_location":{"id":"pmh:oai:RePEc:rif:dpaper:888","doi":null,"is_oa":false,"landing_page_url":"http://www.etla.fi/wp-content/uploads/2012/09/dp888.pdf","pdf_url":"http://www.etla.fi/wp-content/uploads/2012/09/dp888.pdf","source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"preprint"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10419/63675","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054261500","display_name":"Raine Hermans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Raine Hermans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5054261500"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10019","display_name":"Corporate Finance and Governance","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10019","display_name":"Corporate Finance and Governance","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11903","display_name":"Private Equity and Venture Capital","score":0.13449999690055847,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biopharmaceutical-industry","display_name":"biopharmaceutical industry","score":0.7960000038146973},{"id":"https://openalex.org/keywords/biotechnology-companies","display_name":"biotechnology companies","score":0.8790000081062317},{"id":"https://openalex.org/keywords/small-and-medium-sized-enterprises","display_name":"small and medium-sized enterprises","score":0.9259999990463257},{"id":"https://openalex.org/keywords/capital-structure","display_name":"capital structure","score":0.875},{"id":"https://openalex.org/keywords/ownership-structure","display_name":"ownership structure","score":0.9110000133514404},{"id":"https://openalex.org/keywords/venture-capital","display_name":"venture capital","score":0.9079999923706055},{"id":"https://openalex.org/keywords/tekes","display_name":"Tekes","score":0.8569999933242798},{"id":"https://openalex.org/keywords/public-funding","display_name":"government funding","score":0.5799999833106995},{"id":"https://openalex.org/keywords/equity-financing","display_name":"equity financing","score":0.6990000009536743},{"id":"https://openalex.org/keywords/intangible-assets","display_name":"intangible assets","score":0.7289999723434448},{"id":"https://openalex.org/keywords/r-d-investment","display_name":"R&D investment","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6241006851196289},{"id":"https://openalex.org/C39896193","wikidata":"https://www.wikidata.org/wiki/Q380344","display_name":"Descriptive statistics","level":2,"score":0.5157220959663391},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5103866457939148},{"id":"https://openalex.org/C142546437","wikidata":"https://www.wikidata.org/wiki/Q2661195","display_name":"Descriptive research","level":2,"score":0.4329163432121277},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12093687057495117},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0950966477394104},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.05726608633995056},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:RePEc:rif:dpaper:888","doi":null,"is_oa":false,"landing_page_url":"http://www.etla.fi/wp-content/uploads/2012/09/dp888.pdf","pdf_url":"http://www.etla.fi/wp-content/uploads/2012/09/dp888.pdf","source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"preprint"},{"id":"pmh:oai:econstor.eu:10419/63675","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10419/63675","pdf_url":"http://hdl.handle.net/10419/63675","source":{"id":"https://openalex.org/S4306401696","display_name":"Econstor (Econstor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"doc-type:workingPaper"},{"id":"mag:1503699774","doi":null,"is_oa":false,"landing_page_url":"https://EconPapers.repec.org/RePEc:rif:dpaper:888","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RePEc: Research Papers in Economics","raw_type":null}],"best_oa_location":{"id":"pmh:oai:econstor.eu:10419/63675","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10419/63675","pdf_url":"http://hdl.handle.net/10419/63675","source":{"id":"https://openalex.org/S4306401696","display_name":"Econstor (Econstor)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"doc-type:workingPaper"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1503699774.pdf","grobid_xml":"https://content.openalex.org/works/W1503699774.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1590607297","https://openalex.org/W1994463998","https://openalex.org/W2007946665","https://openalex.org/W2057744370","https://openalex.org/W2062299449","https://openalex.org/W2119780569","https://openalex.org/W2125664626","https://openalex.org/W2170790204","https://openalex.org/W2204661759","https://openalex.org/W2752617332","https://openalex.org/W3121131820","https://openalex.org/W3121227072","https://openalex.org/W3122153419","https://openalex.org/W3122520067","https://openalex.org/W3123573210","https://openalex.org/W3124081892","https://openalex.org/W3124114405"],"related_works":["https://openalex.org/W1595315156","https://openalex.org/W2096340627","https://openalex.org/W2025354161","https://openalex.org/W6981213678","https://openalex.org/W4408162896","https://openalex.org/W2388020009","https://openalex.org/W2463988161","https://openalex.org/W2900835570","https://openalex.org/W1564576180","https://openalex.org/W2945798977"],"abstract_inverted_index":{"This":[0],"study":[1],"investigates":[2],"the":[3,33,37,76,101,105,127,132,148,157,167,173,185,190],"capital":[4,54,70,87,144,158,202],"and":[5,10,29,56,89,97,159,192],"ownership":[6,160,175],"structures":[7,20],"of":[8,32,80,143],"small":[9],"medium-sized":[11],"pharmaceutical-related":[12],"biotechnology":[13],"firms":[14,60,121],"(bio-pharmaceutical":[15],"companies)":[16],"in":[17,36,50,95,100,147],"Finland.":[18,81],"These":[19,120],"are":[21,42,48,61,122,139],"also":[22,123],"analyzed":[23],"taking":[24],"into":[25],"account":[26],"general":[27],"characteristics":[28],"intangible":[30,207],"assets":[31,208],"business":[34],"activities":[35,99,194],"industry.":[38],"Relatively":[39],"young":[40],"companies":[41,88,102,106,111],"typically":[43],"owned":[44,63,107],"by":[45,64,109,154],"persons":[46],"that":[47],"active":[49],"business,":[51],"private":[52,85],"venture":[53,86],"companies,":[55],"government":[57],"institutions.":[58],"Older":[59],"mostly":[62,108],"other":[65],"non-financial":[66,110],"companies.":[67,165],"The":[68,136],"major":[69],"loan":[71],"supplier":[72],"has":[73,92],"been":[74,113],"TEKES,":[75],"National":[77],"Technology":[78],"Agency":[79],"Equity":[82],"finance":[83,205],"from":[84],"governmental":[90],"sources":[91],"supported":[93],"growth":[94],"research":[96],"development":[98],"examined.":[103],"However,":[104],"have":[112,126],"able":[114],"to":[115,125,184,188],"generate":[116],"relatively":[117],"high":[118,196],"sales.":[119],"anticipated":[124],"highest":[128],"sales":[129],"potential":[130],"over":[131],"next":[133],"5":[134],"years.":[135],"results":[137],"here":[138],"contrasted":[140],"with":[141,195],"explanations":[142,171],"structure":[145,203],"found":[146],"literature.":[149],"No":[150],"single":[151],"theory":[152],"can":[153,181],"itself":[155],"explain":[156],"patterns":[161,180],"within":[162],"Finnish":[163],"bio-pharmaceutical":[164],"Instead,":[166],"literature":[168],"suggests":[169],"many":[170],"for":[172],"observed":[174],"patterns.":[176],"For":[177],"example,":[178],"different":[179],"be":[182],"related":[183],"owners\u2019":[186],"willingness":[187],"monitor":[189],"managers":[191],"support":[193],"earning":[197],"prospects.":[198],"\u2013":[199],"Biotechnology":[200],";":[201,204,206,209],"pharmaceutical":[210],"industry":[211]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}